Observational studyPloS one2025

Effect of imeglimin on metabolic dysfunction-associated steatotic liver disease in individuals with type 2 diabetes.

Naruyoshi Gyoutoku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.